A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.

Efficient, predictable enforcement of the Hague-Visby Rules is critical to Tanzania’s competitiveness in global supply chains, yet circumstantial evidence suggests systematic delays and uncertainty.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced another successful readout for its ECD program, which is evaluating a blood-based screening test ...

Background The epidemiology of sudden cardiac arrest (SCA) in the Mediterranean area remains unclear. The aim of this study ...

Objective: To explore the effect of dual-cycle teaching model integrating in-class and extracurricular activities in Maternal ...

Background Postoperative ileus (POI) is a common complication after abdominal surgery that significantly delays recovery. Evidence suggests that the general anaesthetic propofol inhibits ...

5 Aix Marseille University, Inserm, IRD, SESSTIM, Sciences Économiques and Sociales de la Santé and Traitement de l’Information Médicale, ISSPAM, Marseille, France Background Peg-interferon (peg-IFN) ...

Background To assess subfoveal choroidal thickness (SFCT) and its associations in school children in a Russian population. Methods The Ural Children Eye Study (UCES), a school-based case-control study ...

In an era marked by tight hospital margins and rising antimicrobial resistance, diagnostics are emerging not just as tools for detection, but as strategic assets that can influence clinical outcomes ...

Torsten Slok, chief economist at Apollo, examines what's been learned about the US labor market from alternative data and what kind of argument could be made by the Federal Reserve to cut interest ...

Researchers from Turku Bioscience Centre at the University of Turku, Finland, have developed a new computational method to interpret complex single-cell data. The method helps researchers identify and ...

Missing data in clinical trials remains an ongoing concern. With the expansion of data privacy efforts and the consequent inability to contact trial participants for follow-up, the magnitude and ...